NEW YORK, NY / ACCESS Newswire / January 28, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are […]

(NASDAQ:BIOA), NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of BioAge Labs, Inc. (NASDAQ: BIOA) pursuant and/or traceable to BioAge's registration statement for the initial public offering conducted on September 26, 2024 (the “IPO”), of the important March 10, 2025 lead

Fort Lauderdale, FL – Florida’s latest property insurance reforms have officially taken effect, bringing significant implications for homeowners in Fort Lauderdale. As premiums continue to rise and hurricane risks remain a pressing concern, the Law Offices of Larry Moskowitz, PA is stepping up to help residents understand their rights, review their policies, and protect their

(NASDAQ:EPIX), SAN DIEGO, Jan. 28, 2025 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired ESSA Pharma Inc. (NASDAQ: EPIX) securities between December 12, 2023 and October 31, 2024. ESSA is a clinical stage pharmaceutical company that focuses on

(NASDAQ:SAVA), NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Cassava Sciences, Inc. (NASDAQ: SAVA) between February 7, 2024 and November 24, 2024, both dates inclusive (the “Class Period”), of the important February 10, 2025 lead plaintiff deadline. SO WHAT: If

NEW YORK CITY, NY / ACCESS Newswire / January 28, 2025 / WHY: New York, N.Y., January 28, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of BioAge Labs, Inc. (NASDAQ:BIOA) pursuant and/or traceable to BioAge’s registration statement for the initial public offering conducted on September 26, 2024 (the

(NASDAQ:SLS), NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that it has entered into a securities purchase agreement with a single healthcare-focused institutional

Family Research Council President Tony Perkins, a former Louisiana state representative, signed on to a letter calling on the organizers of Super Bowl LIX to respect Louisiana's community values and adhere to state laws meant to protect minors from vulgar or objectionable materials and performances. The letter was sent ahead of Super Bowl LIX, which

Colorado's Top Thought Leaders Positively Inform Marketing Department TheUniversity of Denver Daniels College of Businessis pleased to announce its 2024-2025 Marketing Advisory Board. Led by co-chairs Jack Buffington, a professor at the University of Denver, and Jen Lester, CEO of Philosophy Communication, Inc., the board is a dedicated group of industry experts who advise on

A New Solution emerges That Covers Lifetime Tracking and Retrospective Logging SARASOTA, FL / ACCESS Newswire / January 28, 2025 / As tax season approaches, self-employed individuals are seeking software tools to simplify mileage logging and maximize their tax deductions. Not to mention that the business mileage rate of 2025 has been announced. Choosing the